Evidence map›Paper›PMID 27112962›Full record

ArticleEuropean journal of nutrition2017

A combination of scGOS/lcFOS with Bifidobacterium breve M-16V protects suckling rats from rotavirus gastroenteritis.

M Rigo-Adrover, S Saldaña-Ruíz, K van Limpt, K Knipping, J Garssen, J Knol, A Franch, M Castell, F J Pérez-Cano

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Observational
  3. Review
  4. Review
  5. Article
  6. Composition and evolutionary characterization of the gut microbiota in pigs.International microbiology : the official journal of the Spanish Society for Microbiology · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Impact of maternalFrontiers in immunology · 2024
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Frontiers in nutrition · 2022
    Article
  19. A New Extracellular β-Galactosidase ProducingIndian journal of microbiology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

M Rigo-AdroverDepartment of Physiology, Faculty of Pharmacy, University of Barcelona, Av. Joan XXIII s/n, 08028, Barcelona, Spain.
S Saldaña-RuízDepartment of Physiology, Faculty of Pharmacy, University of Barcelona, Av. Joan XXIII s/n, 08028, Barcelona, Spain.
K van LimptNutricia Research, Utrecht, The Netherlands.
K KnippingNutricia Research, Utrecht, The Netherlands.
J GarssenNutricia Research, Utrecht, The Netherlands.
J KnolNutricia Research, Utrecht, The Netherlands.
A FranchDepartment of Physiology, Faculty of Pharmacy, University of Barcelona, Av. Joan XXIII s/n, 08028, Barcelona, Spain.
M CastellDepartment of Physiology, Faculty of Pharmacy, University of Barcelona, Av. Joan XXIII s/n, 08028, Barcelona, Spain.
F J Pérez-CanoDepartment of Physiology, Faculty of Pharmacy, University of Barcelona, Av. Joan XXIII s/n, 08028, Barcelona, Spain. franciscoperez@ub.edu.
Institute for Research and Technology in Food and Agriculture · ESNutricia Research (Netherlands) · NLUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRotavirus (RV) is the leading cause of severe diarrhoea among infants and young children, and although more standardized studies are needed, there is evidence that probiotics can help to fight against RV and other infectious and intestinal pathologies. On the other hand, the effects of prebiotics have not been properly addressed in the context of an RV infection. The aim of this study was to demonstrate a protective role for a specific scGOS/lcFOS 9:1 prebiotic mixture (PRE) separately, the probiotic Bifidobacterium breve M-16V (PRO) separately and the combination of the prebiotic mixture and the probiotic (synbiotic, SYN) in a suckling rat RV infection model.

methodsThe animals received the intervention from the 3rd to the 21st day of life by oral gavage. On day 7, RV was orally administered. Clinical parameters and immune response were evaluated.

resultsThe intervention with the PRO reduced the incidence, severity and duration of the diarrhoea (p < 0.05). The PRE and SYN products improved clinical parameters as well, but a change in stool consistency induced by the PRE intervention hindered the observation of this effect. Both the PRE and the SYN, but not the PRO, significantly reduced viral shedding. All interventions modulated the specific antibody response in serum and intestinal washes at day 14 and 21 of life.

conclusionsA daily supplement of a scGOS/lcFOS 9:1 prebiotic mixture, Bifidobacterium breve M-16V or a combination of both is highly effective in modulating RV-induced diarrhoea in this preclinical model.

Indexed as

Bifidobacterium breveAnimalsAnimals, NewbornAntibodies, ViralBody WeightDiarrheaDisease Models, AnimalFatty Acids, VolatileFecesGastroenteritisImmunoglobulin AImmunoglobulin MPrebioticsProbioticsRatsRats, Inbred LewAntibodies, ViralFatty Acids, VolatileImmunoglobulin AImmunoglobulin MPrebioticsBifidobacterium breveFOSGOSPrebioticProbioticRotavirusSynbiotic

Identifiers

PMID27112962
OpenAlexW2344275145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.